As the Plug and Play GOAL program looks ahead to 2025, it will build on the progress of 2024 to expand its reach, foster collaboration, and create new opportunities for startups and partners.
Global net sales of EPKINLY/TEPKINLY were USD 281 million in 2024. Net product sales in the U.S. and Japan by Genmab were DKK 1,743 million in 2024 compared to DKK 421 million in 2023. EPKINLY was ...
The FDA has granted Fast Track Designation to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).
Formerly an NTUC-backed financial advisory firm, MoneyOwl announced in August 2023 that it will wind down and transfer its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback